These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control. Watanabe T, Temma Y, Okada J, Yamada E, Saito T, Osaki A, Shimda Y, Matsumoto S, Horiguchi K, Ishida E, Kondo Y, Okada K, Takamizawa T, Nakajima Y, Ozawa A, Okada S, Horigome M, Yamada M. Endocr J; 2021 May 28; 68(5):599-603. PubMed ID: 33408313 [Abstract] [Full Text] [Related]
48. The role of circulating sTWEAK in the pathogenesis of Hashimoto's thyroiditis - a pilot study. Altay M, Ateş İ, Yılmaz FM, Topçuoğlu C, Kaplan M. Endokrynol Pol; 2016 Oct 28; 67(6):562-566. PubMed ID: 26884302 [Abstract] [Full Text] [Related]
54. Does Hashimoto's Thyroiditis Increase the Risk of Cardiovascular Disease in Young Type 1 Diabetic Patients? Głowinska-Olszewska B, Borysewicz-Sańczyk H, Sawicka B, Klonowska B, Charemska D, Żelazowska-Rutkowska B, Bossowski A. Front Endocrinol (Lausanne); 2020 Oct 28; 11():431. PubMed ID: 32793113 [Abstract] [Full Text] [Related]